Radiation Dermatitis Clinical Trial
Official title:
Evaluation of a Novel Skin Care Product for the Management of Acute Radiodermatitis in Breast Cancer Patients
Notwithstanding the continuous progress in cancer treatment, patients with cancer still have to cope with quality of life (QoL) - impairing complications. Especially an extensive spectrum of dermatologic toxicities has been associated with cancer treatments. The number and type of cutaneous toxicities have evolved over the past 50 years, paralleling the development of new radiotherapy (RT) techniques. Acute radiodermatitis (ARD) is a distressing and painful skin reaction that occurs in 95% of the patients undergoing RT. Important organizations in the field of oncology and supportive care, such as the MASCC, the ASCO, and the ESMO, have developed guidelines for the management of cancer therapy- related cutaneous toxicities based on available scientific evidence. Still, for some interventions, the evidence of recommendation is moderate to insufficient. Therefore, it is essential to elucidate other new potential management strategies for dermatological complications of cancer treatment. Based on the previously mentioned supportive care guidelines for the RTskin project, a novel emollient to tackle ARD has been developed. The RTskin project general aim is to evaluate the efficacy of a novel skincare product to manage ARD in breast cancer patients.
Primary objective Evaluate the efficacy of a novel emollient for the management of ARD in comparison with the current standard of care in breast cancer patients Secondary Objective 1 Compare the ARD-related symptoms of in breast cancer patients treated with the novel emollient and the standard institutional skin care. Secondary Objective 2 Compare the dermatologic quality of life of in breast cancer patients treated with the novel emollient and the standard institutional skin care. Secondary Objective 3 Correlate the severity of ARD with the applied RT parameters and personal - medical characteristics ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04059809 -
Photobiomodulation for Breast Cancer Radiodermatitis
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT06040983 -
Clinical Investigation on the Treatment of Radiation Induced Dermatitis With FR-101 Chest Dressing
|
N/A | |
| Withdrawn |
NCT05505214 -
Topical Steroids & Bacterial Decolonization for Radiation Dermatitis
|
Phase 2 | |
| Withdrawn |
NCT04593914 -
A Novel Skin Barrier Protectant for Acute Radiodermatitis
|
N/A | |
| Completed |
NCT05450848 -
StrataXRT vs. Standard Clinical Practice in the Prevention and Treatment of Radiation Dermatitis
|
N/A | |
| Active, not recruiting |
NCT05594498 -
A Study of StrataXRT in the Prevention of Radiation Dermatitis in Breast Cancer Patients
|
N/A | |
| Recruiting |
NCT04110977 -
A Reminder App to Reduce Radiation Dermatitis Rates in Patients With Head-and-Neck Cancer
|
N/A | |
| Recruiting |
NCT06158347 -
Efficacy and Safety of Hyperbaric Oxygen Therapy for Radiation Dermatitis in Patients With Localized Breast Cancer
|
N/A | |
| Recruiting |
NCT05553392 -
StrataXRT Versus Aquaphor for the Prevention and Management of Radiation Dermatitis
|
N/A | |
| Active, not recruiting |
NCT04268056 -
Characterization of Skin Microbiome Profile and it's Correlation to Radiation Dermatitis
|
||
| Not yet recruiting |
NCT04888234 -
Evaluation the Effectiveness of Ru-Yi-Jin-Huang Powder for the Radiation-induced Dermatitis.
|
Phase 2 | |
| Terminated |
NCT01597921 -
A DB Randomized Study of R1 and R2 WaterJel / AloeVera Jell in Prevention of Radiation Dermatitis in Breast Cancer
|
N/A | |
| Completed |
NCT00481884 -
Comparing RadiaPlexRx Hydrogel and Standard-of-Care for Radiation Dermatitis in Breast Cancer Patients
|
Phase 3 | |
| Completed |
NCT03494205 -
Urtica Comp. Gel for Prevention and Therapy of Radiation Dermatitis
|
Phase 2 | |
| Completed |
NCT05810194 -
Retrospective Cohort Study Comparing a Novel Gel Dressing vs SoC in the Treatment of Radiation Dermatitis
|
||
| Completed |
NCT03941665 -
Use of Gelronate Gel vs. Aloevera in Preventing/Minimizing Radiation-induced Dermatitis in Breast Cancer Patients
|
N/A | |
| Not yet recruiting |
NCT02051907 -
Clinical Study to Evaluate Safety and Efficacy of KAM1403 Gel to Treat Radiation Dermatitis
|
Phase 2 | |
| Completed |
NCT02839473 -
Hydrosorb® Versus Control in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial
|
Phase 3 | |
| Completed |
NCT00573365 -
LED Photomodulation for Prevention of Post-Radiation Treatment Dermatitis
|
N/A | |
| Completed |
NCT00876642 -
Trial Comparing Best Supportive Care to Aloe Vera Gel
|
Phase 3 |